Basement membrane and vascular remodelling in smokers and chronic obstructive pulmonary disease: A cross-sectional study

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Soltani, Amir ^a   Reid, David W ^a   Sohal, Sukhwinder S ^a   Wood Baker, Richard ^a   Weston, Steve ^a   Muller, H Konrad ^a   Walters, E Haydn ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; AIRWAY REMODELING; ARTICLE; BASEMENT MEMBRANE; BRONCHUS BIOPSY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HISTORY; HUMAN; HUMAN TISSUE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; PREDICTION; RETICULAR BASEMENT MEMBRANE; SMOKING; BIOPSY; BLOOD VESSEL; BRONCHOSCOPY; BRONCHUS; CASE CONTROL STUDY; MIDDLE AGED; PATHOLOGY; VASCULARIZATION;

ADULT; AGED; AIRWAY REMODELING; BASEMENT MEMBRANE; BIOPSY; BLOOD VESSELS; BRONCHI; BRONCHOSCOPY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; YOUNG ADULT;

EID: 77956678363     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-105     Document Type: Article

References (31)

1. James AL, Wenzel S. Clinical relevance of airway remodelling in airway diseases. Eur Respir J 2007, 30:134-155. 10.1183/09031936.00146905, 17601971.
2. Bergeron C, Boulet L-P. Structural Changes in Airway Diseases: Characteristics, Mechanisms, Consequences, and Pharmacologic Modulation. Chest 2006, 129:1068-1087. 10.1378/chest.129.4.1068, 16608960.
3. Knox AJ, Stocks J, Sutcliffe A. Angiogenesis and vascular endothelial growth factor in COPD. Thorax 2005, 60:88-89. 10.1136/thx.2004.030544, 1747302, 15681489.
4. Jeffery PK. Remodeling in Asthma and Chronic Obstructive Lung Disease. Am J Respir Crit Care Med 2001, 164:28S-38.
5. Feltis BN, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, Walters EH. Increased Vascular Endothelial Growth Factor and Receptors: Relationship to Angiogenesis in Asthma. Am J Respir Crit Care Med 2006, 173:1201-1207. 10.1164/rccm.200507-1105OC, 16528018.
6. Walters EH, Reid D, Soltani A, Ward C. Angiogenesis: A potentially critical part of remodelling in chronic airway diseases?. Pharmacology & Therapeutics 2008, 118:128-137.
7. GOLD GIfCOLD Global strategy for the Diagnosis, Mangement and Prevention of Chronic Obstructive Pulmonary Disease. Updated 2007. 2007, GOLD GIfCOLD.
8. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, i:307-310.
10. Richmond I, Booth H, Ward C, Walters EH. Intrasubject variability in airway inflammation in biopsies in mild to moderate stable asthma. Am J Respir Crit Care Med 1996, 153:899-903.
11. Bacci E, Cianchetti S, Carnevali S, Bartoli ML, Dente FL, Di Franco A, Giannini D, Vagaggini B, Paggiaro PL. Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm 2002, 11:293-298. 10.1080/09629350210000015692, 1781674, 12467521.
12. Liesker JJ, Hacken NH, Zeinstra-Smith M, Rutgers SR, Postma DS, Timens W. Reticular basement membrane in asthma and COPD: Similar thickness, yet different composition. Int J Chron Obstruct Pulmon Dis 2009, 4:127-135. 2672795, 19436691.
13. Chanez P, Vignola AM, O'Shaugnessy T, Enander I, Li D, Jeffery PK, Bousquet J. Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med 1997, 155:1529-1534.
14. Jeffery PK. Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2004, 1:176-183. 10.1513/pats.200402-009MS, 16113432.
15. Cornell LD, Smith RN, Colvin RB. Kidney Transplantation: Mechanisms of Rejection and Acceptance. Annual Review of Pathology: Mechanisms of Disease 2008, 3:189-220.
16. Ivanyi B, Kemeny E, Szederkenyi E, Marofka F, Szenohradszky P. The value of electron microscopy in the diagnosis of chronic renal allograft rejection. Modern Pathology 2001, 14:1200-1208. 10.1038/modpathol.3880461, 11743041.
17. Demedts IK, Brusselle GG, Bracke KR, Vermaelen KY, Pauwels RA. Matrix metalloproteinases in asthma and COPD. Curr Opin Pharmacol 2005, 5:257-263. 10.1016/j.coph.2004.12.005, 15907912.
18. Vrugt B, Wilson S, Bron A, Holgate ST, Djukanovic R, Aalbers R. Bronchial angiogenesis in severe glucocorticoid-dependent asthma. Eur Respir J 2000, 15:1014-1021. 10.1034/j.1399-3003.2000.01507.x, 10885418.
19. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669-676. 10.1038/nm0603-669, 12778165.
20. Calabrese C, Bocchino V, Vatrella A, Marzo C, Guarino C, Mascitti S, Tranfa CME, Cazzola M, Micheli P, Caputi M, Marsico SA. Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction. Respiratory Medicine 2006, 100:1415-1422. 10.1016/j.rmed.2005.11.009, 16497496.
21. Zanini A, Chetta A, Saetta M, Baraldo S, Castagnetti C, Nicolini G, Neri M, Olivieri D. Bronchial vascular remodelling in patients with COPD and its relationship with inhaled steroid treatment. Thorax 2009, 64:1019-1024. 10.1136/thx.2009.114629, 19736178.
22. Hashimoto M, Tanaka H, Abe S. Quantitative Analysis of Bronchial Wall Vascularity in the Medium and Small Airways of Patients With Asthma and COPD. Chest 2005, 127:965-972. 10.1378/chest.127.3.965, 15764783.
23. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993, 148:1220-1225.
24. Nagai K, Betsuyaku T, Ito Y, Nasuhara Y, Nishimura M. Decrease of vascular endothelial growth factor in macrophages from long-term smokers. Eur Respir J 2005, 25:626-633. 10.1183/09031936.05.00110504, 15802335.
25. Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T. Decreased Level of Vascular Endothelial Growth Factor in Bronchoalveolar Lavage Fluid of Normal Smokers and Patients with Pulmonary Fibrosis. Am J Respir Crit Care Med 2002, 166:382-385. 10.1164/rccm.2103112, 12153975.
26. Wagner PD. Vascular endothelial growth factor and the pathogenesis of emphysema. The American Journal of Medicine 2003, 114:413-414. 10.1016/S0002-9343(03)00075-5, 12714134.
27. Kasahara Y, Tuder RM, Cool CD, Lynch DA, Flores SC, Voelkel NF. Endothelial Cell Death and Decreased Expression of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor 2 in Emphysema. Am J Respir Crit Care Med 2001, 163:737-744.
28. Michaud SE, Dussault S, Groleau J, Haddad P, Rivard A. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. J Mol Cell Cardiol 2006, 41:275-284. 10.1016/j.yjmcc.2006.05.004, 16806264.
29. Nagai A, West WW, Thurlbeck WM. The National Institutes of Health Intermittent Positive-Pressure Breathing trial: pathology studies. II. Correlation between morphologic findings, clinical findings, and evidence of expiratory air-flow obstruction. Am Rev Respir Dis 1985, 132:946-953.
30. Lambert RK, Codd SL, Alley MR, Pack RJ. Physical determinants of bronchial mucosal folding. J Appl Physiol 1994, 77:1206-1216.
31. Johns DP, Wilson J, Harding R, Walters EH. Airway distensibility in healthy and asthmatic subjects: effect of lung volume history. J Appl Physiol 2000, 88:1413-1420.